State Ledger
Company profile

Faeth Therapeutics, Inc. CIK 1829802

Ticker
FTH (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Austin, TX 78702
Fiscal year end
2025 (FY)
Market Data
Close
$23.02
Change
-$2.96
Change %
-11.39%
Volume
14,216

FTH · trading date Oct 12, 2026 · previous close $25.98 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$21.09M
Total assets
$22.90M
Total liabilities
$4.31M
Stockholders' equity
$18.59M
Cash & equivalents
$8.67M
Operating income
-$22.29M
Operating cash flow
-$20.45M
Capital expenditures
$16.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$20.47M
Free cash flow margin
—
Liabilities / assets
18.8%
Equity / assets
81.2%
CapEx / revenue
—
Operating cash flow / net income
0.97×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$21.09M $22.90M $4.31M $18.59M
2024 — -$30.16M $45.36M $6.98M $38.39M
2023 — -$34.10M $74.37M $9.48M $64.90M
2022 — -$48.59M $118.38M $14.97M $103.41M
2021 — -$36.79M $153.23M $6.71M $146.51M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Austin, TX 78702
701 TILLERY STREET #12 #1010
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies